APA (7th ed.) Citation

Laetsch, T. W., Myers, G. D., Baruchel, A., Dietz, A. C., Pulsipher, M. A., Bittencourt, H., . . . Harris, A. C. (2019). Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: A global, single-arm, phase 2 trial. The lancet oncology, 20(12), 1710-1718. https://doi.org/10.1016/S1470-2045(19)30493-0

Chicago Style (17th ed.) Citation

Laetsch, Theodore W., et al. "Patient-reported Quality of Life After Tisagenlecleucel Infusion in Children and Young Adults with Relapsed or Refractory B-cell Acute Lymphoblastic Leukaemia: A Global, Single-arm, Phase 2 Trial." The Lancet Oncology 20, no. 12 (2019): 1710-1718. https://doi.org/10.1016/S1470-2045(19)30493-0.

MLA (9th ed.) Citation

Laetsch, Theodore W., et al. "Patient-reported Quality of Life After Tisagenlecleucel Infusion in Children and Young Adults with Relapsed or Refractory B-cell Acute Lymphoblastic Leukaemia: A Global, Single-arm, Phase 2 Trial." The Lancet Oncology, vol. 20, no. 12, 2019, pp. 1710-1718, https://doi.org/10.1016/S1470-2045(19)30493-0.